Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Abstract Text:

    jinwei huJinwei Hu,xiangpeng yuanXiangpeng Yuan,maria l belladonnaMaria L Belladonna,john m ongJohn M Ong,sebastian wachsmann-hogiuSebastian Wachsmann-Hogiu,daniel l farkasDaniel L Farkas,keith l blackKeith L Black,john s yuJohn S Yu,

    Dendritic cells (DCs) are potent antigen-presenting cells that play a critical role in priming immune responses to tumor. Interleukin (IL)-23 can act directly on DC to promote immunogenic presentation of tumor peptide in vitro. Here, we evaluated the combination of bone marrow-derived DC and IL-23 on the induction of antitumor immunity in a mouse intracranial glioma model. DCs can be transduced by an adenoviral vector coding single-chain mouse IL-23 to express high levels of bioactive IL-23. Intratumoral implantation of IL-23-expressing DCs produced a protective effect on intracranial tumor-bearing mice. The mice consequently gained systemic immunity against the same tumor rechallenge. The protective effect of IL-23-expressing DCs was comparable with or even better than that of IL-12-expressing DCs. IL-23-transduced DC (DC-IL-23) treatment resulted in robust intratumoral CD8(+) and CD4(+) T-cell infiltration and induced a specific TH1-type response to the tumor in regional lymph nodes and spleen at levels greater than those of nontransduced DCs. Moreover, splenocytes from animals treated with DC-IL-23 showed heightened levels of specific CTL activity. In vivo lymphocyte depletion experiments showed that the antitumor immunity induced by DC-IL-23 was mainly dependent on CD8(+) T cells and that CD4(+) T cells and natural killer cells were also involved. In summary, i.t. injection of DC-IL-23 resulted in significant and effective systemic antitumor immunity in intracranial tumor-bearing mice. These findings suggest a new approach to induce potent tumor-specific immunity to intracranial tumors. This approach may have therapeutic potential for treating human glioma.

    Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Publishing Authors By Initials

    j huJ Hu,x yuanX Yuan,ml belladonnaML Belladonna,jm ongJM Ong,s wachsmann-hogiuS Wachsmann-Hogiu,dl farkasDL Farkas,kl blackKL Black,js yuJS Yu,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Cancer research

    VOLUME: 66

    Page Numbers: 8887-96

    Journal Abbreviation:

    ISSN: 1538-7445

    DAY: 1

    MONTH: Sep

    YEAR: 2006

    Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2984705

    Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

    AFFILIATION: Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News